NYSE · OPHTHALMIC GOODS · LARGE CAP
Bausch & Lomb Corp. BLCO
6 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$5.1B
▲ 6.5% vs FY2024
EPS · FY25
$-1.02
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-5.6%
Net margin · FY25
-7.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 5.1B
Revenue, FY2025 · full 6-year series below
Revenue
Net income
The company lost 7 cents on every revenue dollar this year.
Per share
USD -1.02
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-5.6%
Return on equity, FY2025
ROE
Operating margin2.2%
Net margin-7.1%
Return on assets-2.6%
Each USD of equity lost 6 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
+8.4% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+10.6%
+8.4%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.35B
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 14.0B
total assets, end of FY2025
Total assetsUSD 14.0B
EquityUSD 6.4B
CashUSD 383.0M
Gross debtUSD 5.0B
Net debtUSD 4.7B
Current ratio1.55×
Net debt stands at 72% of equity.
History
6 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
Revenue $B
5.1
4.8
4.1
3.8
3.8
3.4
Operating income $B
0.1
0.2
0.1
0.2
0.3
0.3
EBITDA $B
0.3
0.3
0.3
0.3
0.5
0.4
Income tax $B
0.0
0.1
0.1
0.1
0.1
0.3
Net income $B
−0.4
−0.3
−0.3
0.0
0.2
−0.0
EPS, diluted $
−1.02
−0.90
−0.74
0.02
0.52
−0.05
Dividend / sh $
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
ROE %
−5.6
−4.8
−3.7
0.1
2.0
·
Shares out B
0.35
0.35
0.35
0.35
0.35
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
16 of 16
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed